Pharma and biotech M&A is set to slow globally in 2016
After a feverish 2015, a convergence of factors may cool M&A activity in the sector this year
You must be signed in to read this analysis
What is this?
This summary is from the Oxford Analytica Daily Brief, which analyses geopolitical, economic, social, business and industrial developments on a global and regional basis, providing clients with timely, authoritative analysis every business day of the year. Find out more about the Oxford Analytica Daily Brief, or request a trial.
This summary refers to the following article(s).